-
Cancer Sci: Pembrolizumab monototherapy in patients with advanced ovarian cancer in Japan
Time of Update: 2020-07-14
Interim results of the 2-phase KEYNOTE-100 study (NCT02674061) of 376 patients with advanced recurrent ovarian cancer (ROC) in the past showed that the Bloomberg Zuma single drug treatment was ass
-
JCO: Obesity is a delay again! Large retrospective analysis showed that chemotherapy was poor in obese breast cancer patients.
Time of Update: 2020-07-14
How harmful is obesity? In the case of breast cancer , the higher the BMI and the higher the risk of breast cancer in the Asian population before diagnosis, and after diagnosis, for every 5 kg of w
-
Lancet: The Lancet new article consolidates the status of aspirin "god medicine" and can reduce the risk of colorectal cancer in two years
Time of Update: 2020-07-14
In scientific research, there is never a shortage of "myths" about aspirin Since its birth more than 100 years ago, researchers have been trying to apply the magic drug to prevention and treatment
-
FDA approves FGF23 blocking antibody Crysvita for tumor-induced osteosesasapha (TIO)
Time of Update: 2020-07-14
Ultragenyx Pharmaceuticals and Kyowa Kirin inc announced that the U.S Food and Drug Administration Administration ( FDA ) has approved its fibroblast growth factor 23 (FGF23) blocking antibody Cry
-
Effect of IDH mutation on survival prognosis in patients with high-level meningioma
Time of Update: 2020-07-14
Meningia tumor is a common central nervous system tumor with an annual incidence rate of 8.3 per 100,000, of which 80%-90% of meningioma is a low-grade brain tumor with a recurrence rate of 7%-20% Rec
-
CELL: A New Strategy for Tumor Diagnostic Treatment: Metabolic Detection plus Dietary Treatment
Time of Update: 2020-07-14
Tumor transformation is associated with profound changes in cellular metabolism, but it is largely unknown whether tracking these can improve disease stratification or affect treatment decisions r
-
Nature Cancer: The incidence of colorectal cancer is closely linked to gut microbes
Time of Update: 2020-07-14
A joint study by researchers from the VIB-UGent Center for Inflammation Research and the University of The ate reveals a new mechanism that causes colorectal cancer The researchers found that abnorm
-
GnRH antagonist linzagolix treats uterine fibroids, with positive results in Phase 3 studies
Time of Update: 2020-07-14
ObsEva SA announced data from the 3rd Phase study (PRIMROSE 1 and 2), which evaluated the effectiveness and safety of the GnRH (gonadotropin-releasing hormone) an tagane Yselty (linzagolix) for the
-
Gynecol Oncol: Phase I study of newly diagnosed ovarian cancer, primary peritoneal cancer and intra-abdominal platinum chemotherapy combined with Veliparib and Beivaczumab
Time of Update: 2020-07-14
Improvements in epithelial ovarian cancer , peritoneal cancer or eOC disease-free survival can only be achieved through improved primary treatment Adding polyADP-ribonucleic inhibitors (PARPi) to a
-
Professor Yao Shuzhong: First-line maintenance of PARP inhibitors to maintain therapy biomarkers from BRCA to HRD plus, HRD Score testing helps screening of people benefiting from ovarian cancer
Time of Update: 2020-07-14
With the progress of PARP inhibitor research, the the path of of ovarian cancer is expanding Especially in the first-line maintenance treatment approved by the FDA , from Olapa's use of BRCA muta
-
Large-scale prospective research analysis shows that if you quit smoking, limit alcohol and eat more garlic, you will not have stomach cancer. You have the final say!
Time of Update: 2020-07-14
There is a place in Shandong called Linyi County The place is small, with only 1,833 square kilometers, about one-tenth of Beijing's However, in the study of cancer in China, Linyi County is very fa
-
"PNAS" big breakthrough! Scientists from the three countries jointly developed a new "detoxification version" of erythromycin, the side effects greatly reduced!
Time of Update: 2020-07-14
The drug could be adjusted to reduce its toxic side effects, especially heart damage, without impairing its ability to suppress tumors, according to a new study The study upended conventional thinki
-
Summary of recent important original studies of colorectal cancer
Time of Update: 2020-07-14
The increase in the incidence of colorectal cancer among young people is related to an increase in surgical excision in obese patients there is currently a lack of national studies to test t
-
Clin Cancer Research: Qumetinib Joint 5-FU CRT For Advanced Rectal Cancer
Time of Update: 2020-07-14
BACKGROUND: The RAS/RAF/MEK/ERK signaling pathway is critical to the development of colorectal cancer , and KRAS, NRAS, and BRAF mutations drive tumor tolerance to radiation therapy This study is a
-
JAMA Surg: Cyan green lung targeted inhalation vs intravenous injection for lung cancer tumor edge identification
Time of Update: 2020-07-14
The recognition of tumor edges in surgery is very important for tumor removal, and intravenous indigoma (ICG) has some limitations in lung cancer excision Recently, researchers examined the clinical
-
China integrates tumor electric field treatment into standard program International cutting-edge innovative therapy for patients with glioblastoma
Time of Update: 2020-07-14
Qin Zhiyong said that the clinical prognosis of glioblastoma patients is very poor "Surgery plus chemotherapy and tumor electric field therapy" will become a new standard treatment plan. Chen Jing
-
Application for a new drug for the treatment of hepatocellular carcinoma in PD-1 monoanti-Tisleizumab in Baiji Shenzhou was accepted by NMPA, as well as a summary of Tislelizumab clinical studies
Time of Update: 2020-07-14
Baiji Shenzhou announced that China's National Drug Supervision Management Bureau (NMPA) Drug Evaluation Center (CDE) has accepted Baiji Shenzhou's anti-PD-1 monoanti-retinzumab supplementation dr
-
Guangdong issues first prescription for cancer electric field treatment
Time of Update: 2020-07-14
Guangdong issued the first prescription for the treatment of cancer electric field Zhong Xin Xinhua Guangzhou, June 30 (Cai Minxuan) Zhongshan University Cancer Prevention and Control Center on t
-
Clin Cancer Research: Autophagy inhibitor hydroxychloroquine combined with gisitabin/nab yew alcohol as a preoperative treatment for pancreatic cancer
Time of Update: 2020-07-14
BACKGROUND: Herbert J Zeh et al speculated that autophagy inhibition or enhanced response to chemotherapy in patients with pancreatic cancer , and conducted a randomized controlled trial to evaluat
-
CheckMate-870 results are positive: Odivor (Navuliu monotophosm) is safe and reliable in patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Time of Update: 2020-07-14
On June 30, 2020, The Results of CheckMate-870 were presented at the American Association for Cancer Research's Annual Meeting (AACR 2020) CheckMate-870 is an open-label phase IIIB clinical study de
